← Back to Search

Behavioral Intervention

Behavioral Intervention with financial rewards and coaching for Type 2 Diabetes (COMMITTED2-KC Trial)

N/A

Waitlist Available

Led By Jared Bruce, PhD

Research Sponsored by University of Missouri, Kansas City

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 to 65

Currently receiving treatment for diabetes by a licensed healthcare provider

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 14 weeks

Awards & highlights

COMMITTED2-KC Trial Summary

This trial is testing a program that combines diabetes coaching, financial rewards, and continuous glucose monitoring to see if it can help adults with type 2 diabetes better manage their condition. The study aims to determine

Who is the study for?

Adults with type 2 diabetes in Kansas City who are interested in improving their blood sugar management may qualify for this study. Participants should be willing to follow a diabetes treatment plan, use continuous glucose monitoring, and engage with coaching sessions.Check my eligibility

What is being tested?

The trial is testing a program that combines continuous glucose monitoring with personalized coaching and financial incentives to see if it helps patients better stick to their diabetes treatment plans and manage their blood sugar levels.See study design

What are the potential side effects?

Since the intervention involves behavioral changes rather than medication, side effects are minimal but could include potential stress or anxiety from lifestyle adjustments and the pressure of adhering to the treatment plan.

COMMITTED2-KC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I am currently being treated for diabetes by a healthcare professional.

Select...

I have been diagnosed with type 2 diabetes.

COMMITTED2-KC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 14 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 14 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hemoglobin A1C

Time in target blood glucose range per CGM

Secondary outcome measures

Diabetes Distress Scale

Diabetes Quality of Life Brief Inventory

Motivation and Confidence Ruler

+2 more

COMMITTED2-KC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Behavioral Intervention with financial rewards and coachingExperimental Treatment1 Intervention

Individuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.

Group II: ControlActive Control1 Intervention

Individuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Missouri, Kansas CityLead Sponsor

69 Previous Clinical Trials

32,604 Total Patients Enrolled

Jared Bruce, PhDPrincipal InvestigatorUniversity of Missouri, Kansas City

4 Previous Clinical Trials

521 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which specific criteria must individuals meet to be eligible for enrollment in this research study?

"Individuals aged between 18 and 65 years with a diagnosis of type 2 diabetes are eligible to participate in this clinical trial, which aims to enroll approximately 40 participants."

Answered by AI

What are the anticipated results that researchers hope to achieve from conducting this medical study?

"The main objective of this research, to be evaluated from baseline to 14 weeks, is the measurement of Hemoglobin A1C levels. Additional endpoints encompass patient-reported outcomes such as Diabetes Quality of Life Brief Inventory, Motivation and Confidence Ruler questionnaires, along with the assessment through the Diabetes Distress Scale questionnaire."

Answered by AI

Is there an age limit for participation in this research study, specifically for those under 35 years old?

"Eligibility requirements specify that individuals aged between 18 and 65 are suitable candidates for participation in this study. It is noteworthy that there are a substantial number of clinical trials available for both the pediatric population, with 185 trials targeting patients under 18 years old, and the elderly demographic, with 1156 trials focusing on individuals over 65 years old."

Answered by AI

Is the enrollment phase for this investigation currently ongoing?

"According to clinicaltrials.gov data, recruitment is currently not active for this particular trial. The trial was initially listed on 5/1/2024 and last updated on 4/15/2024. It should be noted that while this study is not recruiting participants presently, there are a total of 1475 other trials actively seeking volunteers at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

2024. "Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06374186.